Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.94
+0.57 (8.95%)
At close: May 21, 2026, 4:00 PM EDT
7.06
+0.12 (1.73%)
After-hours: May 21, 2026, 6:20 PM EDT
Eupraxia Pharmaceuticals Employees
Eupraxia Pharmaceuticals had 49 employees as of December 31, 2025. The number of employees increased by 16 or 48.48% compared to the previous year.
Employees
49
Change (1Y)
16
Growth (1Y)
48.48%
Revenue / Employee
n/a
Profits / Employee
-$959,139
Market Cap
434.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 49 | 16 | 48.48% | 49 | 0 |
| Dec 31, 2024 | 33 | 4 | 13.79% | 33 | 0 |
| Dec 31, 2023 | 29 | 8 | 38.10% | 29 | 0 |
| Dec 31, 2022 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2021 | 21 | 9 | 75.00% | 19 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 104 |
| OmniAb | 89 |
| Century Therapeutics | 78 |
| Lexeo Therapeutics | 59 |
| Zura Bio | 40 |
EPRX News
- 1 day ago - Eupraxia Pharmaceuticals initiated with a Buy at Stifel - TheFly
- 9 days ago - Eupraxia Pharmaceuticals reports Q1 net loss ($12.7M) vs. ($6.8M) last year - TheFly
- 9 days ago - Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 15 days ago - Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week - GlobeNewsWire
- 16 days ago - Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW) - GlobeNewsWire
- 20 days ago - Eupraxia Pharmaceuticals names Dr. Jeymi Tambiah as Chief Medical Officer - TheFly
- 20 days ago - Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting - GlobeNewsWire